These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20538112)

  • 1. Serum fetuin-A, cardiovascular risk factors, and six-year follow-up outcome in patients with coronary heart disease.
    Roos M; von Eynatten M; Heemann U; Rothenbacher D; Brenner H; Breitling LP
    Am J Cardiol; 2010 Jun; 105(12):1666-72. PubMed ID: 20538112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study.
    von Eynatten M; Breitling LP; Roos M; Baumann M; Rothenbacher D; Brenner H
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2327-35. PubMed ID: 22679309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events.
    Palikhe A; Sinisalo J; Seppänen M; Haario H; Meri S; Valtonen V; Nieminen MS; Lokki ML
    Am J Cardiol; 2007 Apr; 99(7):890-5. PubMed ID: 17398178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.
    Wang AY; Woo J; Lam CW; Wang M; Chan IH; Gao P; Lui SF; Li PK; Sanderson JE
    Nephrol Dial Transplant; 2005 Aug; 20(8):1676-85. PubMed ID: 15899935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.
    Engström G; Hedblad B; Janzon L; Lindgärde F
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):392-7. PubMed ID: 17568238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke.
    Weikert C; Stefan N; Schulze MB; Pischon T; Berger K; Joost HG; Häring HU; Boeing H; Fritsche A
    Circulation; 2008 Dec; 118(24):2555-62. PubMed ID: 19029462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men.
    Tuomainen AM; Nyyssönen K; Laukkanen JA; Tervahartiala T; Tuomainen TP; Salonen JT; Sorsa T; Pussinen PJ
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2722-8. PubMed ID: 17932311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum albumin predicts cardiac adverse events in patients with advanced atherosclerosis - interrelation with traditional cardiovascular risk factors.
    Schillinger M; Exner M; Mlekusch W; Amighi J; Sabeti S; Schlager O; Wagner O; Minar E
    Thromb Haemost; 2004 Mar; 91(3):610-8. PubMed ID: 14983239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.
    Roumie CL; Choma NN; Kaltenbach L; Mitchel EF; Arbogast PG; Griffin MR
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1053-63. PubMed ID: 19637402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor functional status based on the New York Heart Association classification exposes the coronary patient to an elevated risk of ischemic stroke.
    Koren-Morag N; Goldbourt U; Tanne D
    Am Heart J; 2008 Mar; 155(3):515-20. PubMed ID: 18294489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease.
    Grandi NC; Breitling LP; Hahmann H; Wüsten B; März W; Rothenbacher D; Brenner H
    Heart; 2011 Aug; 97(15):1215-21. PubMed ID: 21586795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a population-based 18-year follow-up study.
    Kilhovd BK; Juutilainen A; Lehto S; Rönnemaa T; Torjesen PA; Birkeland KI; Berg TJ; Hanssen KF; Laakso M
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):815-20. PubMed ID: 15692098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease.
    Tonelli M; Sacks F; Pfeffer M; Gao Z; Curhan G;
    Circulation; 2005 Oct; 112(17):2627-33. PubMed ID: 16246962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
    van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
    Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
    Rothenbacher D; Koenig W; Brenner H
    Arch Intern Med; 2006 Dec 11-25; 166(22):2455-60. PubMed ID: 17159010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.
    Hooning MJ; Botma A; Aleman BM; Baaijens MH; Bartelink H; Klijn JG; Taylor CW; van Leeuwen FE
    J Natl Cancer Inst; 2007 Mar; 99(5):365-75. PubMed ID: 17341728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble intercellular adhesion molecules, soluble vascular cell adhesion molecules, and risk of coronary heart disease.
    Shai I; Pischon T; Hu FB; Ascherio A; Rifai N; Rimm EB
    Obesity (Silver Spring); 2006 Nov; 14(11):2099-106. PubMed ID: 17135628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.